RhumbLine Advisers’s Pomdoctor Ltd POM Stock Holding History

RhumbLine Advisers’s Portfolio POM Stock Details POM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60	Sell	41 -1	-2%	-$4	﹤0.01%	4103
2026 Q1	$192	Hold	42	–	–	﹤0.01%	4039
2025 Q4	$221	Buy	+42	New	+$2.74K	﹤0.01%	4082

Other funds holding POM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

RhumbLine Advisers's POM Position: Q2 2026 in Review

RhumbLine Advisers reduced its Pomdoctor Ltd (POM) stake by 2.4% in Q2 2026, selling an estimated $4 and leaving 41 shares worth $60. The position accounts for ﹤0.01% of the portfolio, ranked #4103.

RhumbLine Advisers first reported a position in POM in Q4 2025 and has held it in 3 quarters since. The position peaked at $221 in Q4 2025. 6 funds tracked by Wall St. Rank hold POM as of Q2 2026.

RhumbLine Advisers held 41 shares of Pomdoctor Ltd worth $60 as of Q2 2026.
RhumbLine Advisers sold 1 Pomdoctor Ltd share in Q2 2026, an estimated $4.
Pomdoctor Ltd made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #4103 holding.
RhumbLine Advisers first reported a position in Pomdoctor Ltd in Q4 2025 and has held it in 3 quarters since.
RhumbLine Advisers's Pomdoctor Ltd position peaked at $221 in Q4 2025.
6 funds tracked by Wall St. Rank held Pomdoctor Ltd as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.